Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders

Social Psychiatry and Psychiatric Epidemiology

Volumn 45, Issue 5, 2010, Pages 523-529

  Alenius, Malin ^a,b   Hammarlund Udenaes, Margareta ^a   Hartvig, Per ^c   Lindström, Leif ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Apoteket AB   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Health knowledge; Insight; Psychotic disorders; Schizophrenia; Treatment outcome

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PARANOID SCHIZOPHRENIA; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOSIS; QUESTIONNAIRE; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ATTITUDE TO HEALTH; AWARENESS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIA, PARANOID; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 77953253294     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-009-0096-3     Document Type: Article

References (40)

1. Alenius M, Hammarlund-Udenaes M, Hartvig P, Sundquist S, Lindström L (2009) Treatment response in psychotic patients classified according to social and clinical needs, drug side effects and previous treatment: a method to identify functional remission. Compr Psychiatry (In Press). doi:10.1016/j. comppsych. 2008.1011.1001
2. Andres K, Pfammatter M, Fries A, Brenner HD (2003) The significance of coping as a therapeutic variable for the outcome of psychological therapy in schizophrenia. Eur Psychiatry 18 (4):149-154 (Pubitemid 36745198)
3. Arvidsson H (2003) Test-retest reliability of the Camberwell Assessment of Need (CAN). Nord J Psychiatry 57 (4):279-283
4. Beiser M, Iacono WG (1990) An update on the epidemiology of schizophrenia. Can J Psychiatry 35 (8):657-668
5. Borell P, Orhagen T, Délia G (1995) Vad vet patienter med schizofreni om sin sjukdom? Scand J Behaviour Therapy 24 (2-3): 63-74
6. Carter DM, Mackinnon A, Copolov DL (1996) Patients' strategies for coping with auditory hallucinations. J Nerv Ment Dis 184 (3):159-164
7. Clary C, Dever A, Schweizer E (1992) Psychiatric inpatients' knowledge of medication at hospital discharge. Hosp Community Psychiatry 43 (2):140-144
8. Cooke M, Peters E, Fannon D, Anilkumar AP, Aasen I, Kuipers E, Kumari V (2007) Insight, distress and coping styles in schizophrenia. Schizophr Res 94 (1-3): 12-22
9. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C (2005) Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 62 (7):717-724
10. de Hert M, Wampers M, Thys E, Wieselgren I, Lindström E, Peuskens J (2002) Validation study of PECC (psychosis evaluation tool for common use by caregivers): interscale validity and inter-rater reliability. Int J Psych Clin Pract 6:135-140
11. Drake RJ, Dunn G, Tarrier N, Bentall RP, Haddock G, Lewis SW (2007) Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry 68 (1):81-86
12. Eccles R (2007) The power of the placebo. Curr Allergy Asthma Rep 7 (2):100-104
13. Falloon I, Fadden G, Borell P, Kärräng L, Ivarsson B, Malm U (1997) Integrerad psykiatri. Psykologia ISBN 91-630-5438-8 (1-349
14. Falloon IR (1988) Expressed emotion: current status. Psychol Med 18 (2):269-274
15. Farhall J, Greenwood KM, Jackson HJ (2007) Coping with hallucinated voices in schizophrenia: a review of self-initiated strategies and therapeutic interventions. Clin Psychol Rev 27 (4):476-493
16. Geers AL, Kosbab K, Helfer SG, Weiland PE, Wellman JA (2007) Further evidence for individual differences in placebo responding: an interactionist perspective. J Psychosom Res 62 (5):563-570
17. Geller JL (1982) State hospital patients and their medication-do they know what they take? Am J Psychiatry 139 (5):611-615
18. Hansson L, Bjorkman T, Svensson B (1995) The assessment of needs in psychiatric patients. Interrater reliability of the Swedish version of the Camberwell Assessment of Needs instrument and results from a cross-sectional study. Acta Psychiatr Scand 92 (4):285-293
19. Harrow M, Sands JR, Silverstein ML, Goldberg JF (1997) Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study. Schizophr Bull 23 (2):287-303
20. Heila H, Haukka J, Suvisaari J, Lonnqvist J (2005) Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychol Med 35 (5):725-732
21. Johansen O, Brox J, Flaten MA (2003) Placebo and nocebo responses, cortisol, and circulating beta-endorphin. Psychosom Med 65 (5):786-790
22. Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45 (9):789-796
23. Kikkert MJ, Schene AH, Koeter MW, Robson D, Born A, Helm H, Nose M, Goss C, Thornicroft G, Gray RJ (2006) Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophr Bull 32 (4):786-794
24. Kingdon D, Gibson A, Kinoshita Y, Turkington D, Rathod S, Morrison A (2008) Acceptable terminology and subgroups in schizophrenia: an exploratory study. Soc Psychiatry Psychiatr Epidemiol 43 (3):239-243
25. Ko NY, Yeh ML, Hsu ST, Chung HH, Yen CF (2006) Investigation of insight formation using narrative analyses of people with schizophrenia in remission. J Nerv Ment Dis 194 (2):124-127
26. Lee PW, Lieh-Mak F, Yu KK, Spinks JA (1993) Coping strategies of schizophrenic patients and their relationship to outcome. Br J Psychiatry 163:177-182
27. Limosin F, Loze JY, Philippe A, Casadebaig F, Rouillon F (2007) Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res 94 (1-3): 23-28
28. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU Side Effect Rating Scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334:1-100
29. Link J, Haggard R, Kelly K, Forrer D (2006) Placebo/nocebo symptom reporting in a sham herbal supplement trial. Eval Health Prof 29 (4):394-406
30. Macpherson R, Double DB, Rowlands RP, Harrison DM (1993) Long-term psychiatric patients' understanding of neuroleptic medication. Hosp Community Psychiatry 44 (1):71-73
31. Nes LS, Segerstrom SC (2006) Dispositional optimism and coping: a meta-analytic review. Pers Soc Psychol Rev 10 (3):235-251
32. Nuechterlein KH, Dawson ME (1984) A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 10 (2):300-312
33. Osby U, Correia N, Brandt L, Ekbom A, Sparen P (2000) Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophr Res 45 (1-2): 21-28
34. Peuskens J (1999) The evolving definition of treatment resistance. J Clin Psychiatry 60 (Suppl 12):4-8
35. Phelan M, Slade M, Thornicroft G, Dunn G, Holloway F, Wykes T, Strathdee G, Loftus L, McCrone P, Hayward P (1995) The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. Br J Psychiatry 167 (5):589-595
36. Saeedi H, Addington J, Addington D (2007) The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up. Schizophr Res 89 (1-3): 123-128
37. Sharma T, Antonova L (2003) Cognitive function in schizophrenia. deficits, functional consequences, and future treatment. Psychiatr Clin North Am 26 (1):25-40
38. Wieselgren IM, Lindstrom LH (1996) A prospective 1-5-year outcome study in first-admitted and readmitted schizophrenic patients: relationship to heredity, premorbid adjustment, duration of disease and education level at index admission and neuroleptic treatment. Acta Psychiatr Scand 93 (1):9-19
39. Zubin J, Spring B (1977) Vulnerability: a new view of schizophrenia. J Abnorm Psychol 86 (2):103-126
40. Zubin J, Steinhauer SR, Day R, van Kammen DP (1985) Schizophrenia at the crossroads: a blueprint for the 80s. Compr Psychiatry 26 (3):217-240